The Pfizer vaccine for children in this age group is a series of two doses delivered 21 days apart, just as it is for older children and adults. For children ages 5 to 11, however, each dose is smaller (10 micrograms) than the one used for individuals 12 and older (30 micrograms).
New and Established Memorial Hermann Patients
Non-Memorial Hermann Patients
The FDA evaluated data from 3,100 pediatric study participants to ensure that each vaccine is safe. Based on this research, the American Academy of Pediatrics recommends that anyone who is eligible to receive the COVID-19 vaccine get vaccinated as soon as possible.
While most children with COVID-19 have mild symptoms or have no symptoms at all, severe illness and death have been reported in children under the age of 1, as well as in children with underlying health conditions. Vaccines are helpful in preventing illness and disease, and the COVID-19 vaccine is no different. Getting children vaccinated against COVID-19 protects them from developing severe complications from COVID-19 and may reduce the chance they could spread the infection to other more vulnerable family members and friends. Clinical trials in children ages 5 to 11 years found the vaccine to be 90.7 percent effective in preventing symptomatic COVID-19.
We recognize parents may have questions about the safety and efficacy of the COVID-19 vaccine for their younger children. To help you and your loved ones make an informed decision, please click here for resources and frequently asked questions.